Trial Profile
A Randomized Phase II Trial of Maintenance Therapy With BMN 673 or Placebo in Extensive Disease Small Cell Lung Cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2015
Price :
$35
*
At a glance
- Drugs Talazoparib (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Feb 2015 New trial record